Recombinant Human Neurexin 2 alpha Isoform 2 Fc Chimera, CF

• Reactivity: Hu
• Applications: Bioactivity
• Format: Carrier-Free

Recombinant Human Neurexin 2 alpha Isoform 2 Fc Chimera, CF Summary

• Details of Functionality: Measured by its binding ability in a functional ELISA.

  When Recombinant Human Neurexin 2 alpha /NRXN2a Fc Chimera is coated at 2 μg/mL, biotinylated recombinant rat NXPH-1 binds with an apparent K_D <10 nM.

• Source: Chinese Hamster Ovary cell line, CHO-derived human Neurexin 2 alpha/NRXN2a protein
  

  Human Neurexin 2 alpha (Met1 - Thr1566) Accession # NP_620060	IEGRMD	Human IgG1 (Pro100 - Lys330)
  N-terminus		C-terminus

• Accession #: NP_620060
• N-terminal Sequence: Leu29
• Structure / Form: Disulfide-linked homodimer
• Protein/Peptide Type: Recombinant Proteins
• Gene: NRXN2
• Purity: >95%, by SDS-PAGE under reducing conditions and visualized by silver stain
• Endotoxin Note: <0.10 EU per 1 μg of the protein by the LAL method.

Applications/Dilutions

• Dilutions:
  • Bioactivity
• Theoretical MW: 193 kDa (monomer).
  Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
• SDS-PAGE: 200-250 kda, reducing conditions

Packaging, Storage & Formulations

• Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 3 months, -20 to -70 °C under sterile conditions after reconstitution.
• Buffer: Lyophilized from a 0.2 μm filtered solution in PBS.
• Purity: >95%, by SDS-PAGE under reducing conditions and visualized by silver stain
• Reconstitution Instructions: Reconstitute at 100 μg/mL in PBS.

Notes

This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.

Alternate Names for Recombinant Human Neurexin 2 alpha Isoform 2 Fc Chimera, CF

• Neurexin 2 alpha 2
• NRXN2

Background

Neurexin 2, also known as NRXN2, is a neuronal type I transmembrane molecule that is encoded by one of three Neurexin genes (1, 2). Mature human Neurexin 2 alpha is an approximately 200 kDa N- and O‑glycosylated protein with a 1608 amino acid (aa) extracellular domain (ECD) and a 55 aa cytoplasmic domain. The ECD contains six LNS domains interspersed with three EGF-like domains and a juxtamembrane O‑glycosylation region (1 ‑ 3). The ECD of human Neurexin 2 alpha shares 98% and 99% aa sequence identity with mouse and rat Neurexin 2 alpha , respectively. Transcription of the Neurexin 2 gene from an internal promoter gives rise to Neurexin 2 beta which lacks the first five LNS domains and all of the EGF-like domains (3, 4). Human Neurexin 2 alpha is combinatorially spliced at five canonical sites in the ECD, giving rise to nearly 200 potential isoforms (4). This recombinant protein (isoform 2 according to SwissProt # Q9P2S2) does not contain inserts at splice sites 1, 2, 3,or 4. Neurexin 2 alpha is primarily expressed in the brain where it is localized to presynaptic terminals (3, 5, 6). It binds Neurexophilin 1 and 3, Neuroligin 2, and Dystroglycan (7 ‑ 9). Only Neurexin 2 isoforms that lack the insert at splice site 4 additionally bind LRRTM2 (10). The interaction between Neurexins and Neuroligins is complex and is restricted to particular combinations of splice forms of each binding partner (11). These interactions promote the differentiation and maintenance of postsynaptic GABA and NMDA but not AMPA terminals (8, 12). At presynaptic terminals as well as in pituitary melanotrophs, alpha Neurexins are required for coupling voltage-dependent calcium channel signaling to neurotransmitter or hormone release (13 ‑ 15).

1. Craig, A.M. and Y. Kang (2007) Curr. Opin. Neurobiol. 17:43.
2. Lise, M.-F. and A. El-Husseini (2006) Cell. Mol. Life Sci. 63:1833.
3. Ushkaryov, Y.A. et al. (1992) Science 257:50.
4. Rowen, L. et al. (2002) Genomics 79:587.
5. Dean, C. et al. (2003) Nat. Neurosci. 7:708.
6. Ullrich, B. et al. (1995) Neuron 14:497.
7. Missler, M. et al. (1998) J. Biol. Chem. 273:34716.
8. Kang, Y. et al. (2008) J. Biol. Chem. 283:2323.
9. Sugita, S. et al. (2001) J. Cell Biol. 154:435.
10. Siddiqui, T.J. et al. (2010) J. Neurosci. 30:7495.
11. Boucard, A.A. et al. (2005) Neuron 48:229.
12. Kattenstroth, G. et al. (2004) Proc. Natl. Acad. Sci. 101:2607.
13. Missler, M. et al. (2003) Nature 423:939.
14. Zhang, W. et al. (2005) J. Neurosci. 25:4330.
15. Dudanova, I. et al. (2006) J. Neurosci. 26:10599.

Publications for Neurexin 2 alpha/NRXN2a (6636-NX)(1)

Publication using 6636-NX

• J Brito-More, MV Lourenco, MM Oliveira, JF Vital, FC Ribeiro, JH Ledo, LP Diniz, MH Magdesian, HM Melo, F Barros-Ara, JM de Souza, SV Alves-Leon, FC Gomes, JR Clarke, CP Figueiredo, FG De Felice, ST Ferreira Interaction of A? Oligomers with Neurexin 2? and Neuroligin 1 Mediates Synapse Damage and Memory Loss in Mice J. Biol. Chem, 2017-03-10;0(0):. 2017-03-10 [PMID: 28283575] (Bioassay, Mouse)

Bioinformatics

• Gene Symbol: NRXN2
• Uniprot:
  • NP_620060()